# CAR-T Therapy Targeting CD19 and BCMA in Highly Sensitized Kidney Transplant Participants

> **NCT07350837** · EARLY_PHASE1 · RECRUITING · sponsor: **Tongji Hospital** · enrollment: 12 (estimated)

## Conditions studied

- Highly Sensitized Patients Awaiting Kidney Transplant

## Interventions

- **DRUG:** AZD0120

## Key facts

- **NCT ID:** NCT07350837
- **Lead sponsor:** Tongji Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-28
- **Primary completion:** 2026-12-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07350837

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07350837, "CAR-T Therapy Targeting CD19 and BCMA in Highly Sensitized Kidney Transplant Participants". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07350837. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*